The evolving biology of cell reprogramming

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 366, Issue 1575, 2011, Pages 2183-2197

  Wilmut, Ian ^a   Sullivan, Gareth ^a   Chambers, Ian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Disease modelling; Pluripotency; Regenerative medicine; Reprogramming; Stem cells; Transcription factors

Indexed keywords

CYTOLOGY; EVOLUTIONARY BIOLOGY; GOLD; MOLECULAR ANALYSIS; PHENOTYPE; PUBLIC HEALTH; SYMPTOM;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; HUMAN; MUTATION; NUCLEAR REPROGRAMMING; PHYSIOLOGY; PLURIPOTENT STEM CELL; REGENERATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; MUTATION; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS; REGENERATION;

EID: 79960069146     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0051     Document Type: Article

References (157)

1. Gurdon, J. B., Laskey, R. A. & Reeves, O. R. 1975 The developmental capacity of nuclei transplanted from keratinized skin cells of adult frogs. J. Embryol. Exp. Morphol. 34, 93-112.
2. Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J. & Campbell, K. H. S. 1997 Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810-813. (doi:10.1038/385810a0)
3. Tada, M., Tada, T., Lefebvre, L., Barton, S. C. & Azim Surani, M. 1997 Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J. 16, 6510-6520. (doi:10.1093/emboj/16.21.6510)
4. Lassar, A. B., Paterson, B. M. & Weintraub, H. 1986 Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell 47, 649-656. (doi:10.1016/0092-8674(86)90507-6)
5. Hakelien, A. M., Landsverk, H. B., Robl, J.M., Skålhegg, B. S. & Collas, P. 2002 Reprogramming fibroblasts to expressT-cell functions using cell extracts. Nat. Biotechnol. 20, 460-466. (doi:10.1038/nbt0502-460)
6. Takahashi, K. & Yamanaka, S. 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676. (doi:10.1016/j.cell.2006.07.024)
7. Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., Chiba, T. & Yamanaka, S. 2008 Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699-702. (doi:10.1126/science.1154884)
8. Hanna, J. et al. 2008 Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133, 250-264. (doi:10.1016/j.cell.2008.03.028)
9. Kim, J. B. et al. 2008 Pluripotent stem cells induced from adult neural stemcells by reprogramming with two factors. Nature 454, 646-650. (doi:10.1038/nature07061)
10. Park, I. H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W. & Daley, G. Q. 2008 Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146. (doi:10.1038/nature06534)
11. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. & Yamanaka, S. 2007 Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872. (doi:10.1016/j.cell.2007.11.019)
12. Yu, J. et al. 2007 Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920. (doi:10.1126/science.1151526)
13. Okita, K. & Yamanaka, S. 2011 Induced pluripotent stem cells: opportunities and challenges. Phil. Trans. R. Soc. B366, 2198-2207. (doi:10.1098/rstb.2011.0016)
14. Brambrink, T., Foreman, R., Welstead, G. G., Lengner, C. J., Wernig, M., Suh, H. & Jaenisch, R. 2008 Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2, 151-159. (doi:10.1016/j.stem.2008.01.004)
15. Okita, K., Ichisaka, T. & Yamanaka, S. 2007 Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317. (doi:10.1038/nature05934)
16. Park, I. H. et al. 2008 Disease-specific induced pluripotent stem cells. Cell 134, 877-886. (doi:10.1016/j.cell.2008.07.041)
17. Ezashi, T., Telugu, B. P. V. L., Alexenko, A. P., Sachdev, S., Sinha, S. & Roberts, R. M. 2009 Derivation of induced pluripotent stem cells from pig somatic cells. Proc. Natl Acad. Sci. USA 106, 10 993-10 998. (doi:10.1073/pnas.0905284106)
18. Li, Y., Cang, M., Lee, A. S., Zhang, K., Liu, D. & Kaufman, D. Reprogramming of sheep fibroblasts into pluripotency under a drug-inducible expression of mouse-derived defined factors. PLoS ONE 6, e15947. (doi:10.1371/journal.pone.0015947)
19. Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P. & Woltjen, K. 2009 Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771-775. (doi:10.1038/ nature07864)
20. Nagy, K. et al. In press. Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev. (doi:10.1007/S12015-011-9239-5)
21. Li, W. et al. 2009 Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4, 16-19. (doi:10.1016/j.stem.2008.11.014)
22. Woltjen, K. et al. 2009 piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766-770. (doi:10.1038/nature07863)
23. Mali, P. et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency- associated genes. Stem Cells 28, 713-720. (doi:10.1002/stem.402)
24. Chang, C. W., Lai, Y.-S., Pawlik, K. M., Liu, K., Sun, C.-W., Li, C., Schoeb, T. R. & Townes, T. M. 2009 Polycistronic lentiviral vector for 'hit and run' reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 27, 1042-1049. (doi:10.1002/stem.39)
25. Soldner, F. et al. 2009 Parkinson's disease patientderived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977. (doi:10.1016/j.cell.2009.02.013)
26. Si-Tayeb, K., Noto, F. K., Sepac, A., Sedlic, F., Bosnjak, Z. J., Lough, J. W. & Duncan, S. A. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev. Biol. 10, 81. (doi:10.1186/1471213X-10-81)
27. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. 2008 Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949-953. (doi:10.1126/science.1164270)
28. Gonzalez, F., Barragan Monasterio, M., Tiscornia, G., Montserrat Pulido, N., Vassena, R., Batlle Morera, L., Rodriguez Piza, I. & Belmonte, J. C. I. 2009 Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector. Proc. Natl Acad. Sci. USA 106, 8918-8922. (doi:10.1073/pnas.0901471106)
29. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I. & Thomson, J. A. 2009 Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797-801. (doi:10.1126/ science.1172482)
30. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. 2008 Induced pluripotent stem cells generated without viral integration. Science 322, 945-949. (doi:10.1126/science.1162494)
31. Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. & Hasegawa, M. 2009 Efficient induction of transgenefree human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 85, 348-362. (doi:10.2183/pjab.85.348)
32. Kim, D. et al. 2009 Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472-476. (doi:10.1016/j. stem.2009.05.005)
33. Zhou, H. et al. 2009 Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384. (doi:10.1016/j.stem.2009.04.005)
34. Feng, B., Ng, J.-H., Heng, J.-C. D. & Ng, H.-H. 2009 Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 4, 301-312. (doi:10.1016/j.stem.2009.03.005)
35. Yu, J., Chau, K. F., Vodyanik, M. A., Jiang, J., Jiang, Y. & Pera, M. Efficient feeder-free episomal reprogramming with small molecules. PLoS ONE 6, e17557. (doi:10.1371/journal.pone.0017557)
36. Narsinh, K. H., Jia, F., Robbins, R. C., Kay, M. A., Longaker, M. T. & Wu, J. C. Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat. Protoc. 6, 78-88. (doi:10.1038/nprot.2010.173)
37. Jia, F. et al. A nonviral minicircle vector for deriving human iPS cells. Nat. Methods 7, 197-199. (doi:10.1038/nmeth.1426)
38. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630. (doi:10.1016/j.stem.2010.08.012)
39. Nishimura, K. et al. Development of defective and persistent Sendai virus vector: a unique gene delivery/ expression system ideal for cell reprogramming. J. Biol. Chem. 286, 4760-4771. (doi:10.1074/jbc. M110.183780)
40. Kim, J. B., Greber, B., Araúzo-Bravo, M. J., Meyer, J., Park, K. I., Zaehres, H. & Schöler, H. R. 2009 Direct reprogramming of human neural stem cells by OCT4. Nature 461, 643-649. (doi:10.1038/nature08436)
41. Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T. W., Smith, A. & Goodell, M. A. 2008 Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6, e253. (doi:10.1371/journal.pbio.0060253)
42. Wernig, M., Lengner, C. J., Hanna, J., Lodato, M. A., Steine, E., Foreman, R., Staerk, J., Markoulaki, S. & Jaenisch, R. 2008 A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 26, 916-924. (doi:10.1038/nbt1483)
43. Efe, J. A. & Deng, S. 2011 The evolving biology of small molecules: controlling cell fate and identity. Phil. Trans. R. Soc. B 366, 2208-2221. (doi:10.1098/rstb.2011.0006)
44. Lin, T. et al. 2009 A chemical platform for improved induction of human iPSCs. Nat. Methods 6, 805-808. (doi:10.1038/nmeth.1393)
45. Hanna, J. et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl Acad. Sci. USA 107, 9222-9227. (doi:10.1073/pnas.1004584107)
46. Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Södhof, T. C. & Wernig, M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463, 1035-1041. (doi:10.1038/nature08797)
47. Ieda, M. et al. 2010 Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386. (doi:10.1016/j.cell.2010.07.002)
48. Szabo, E. et al. 2010 Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468, 521-526. (doi:10.1038/nature09591)
49. Finch, B. W. & Ephrussi, B. 1967 Retention of multiple developmental potentialities by cells of a mouse testicular teratocarcinoma during prolonged culture in vitro and their extinction upon hybridization with cells of permanent lines. Proc. Natl Acad. Sci. USA 57, 615-621. (doi:10.1073/pnas.57.3.615)
50. Sherwin, J. R., Freeman, T. C., Stephens, R. J., Kimber, S., Smith, A. G., Chambers, I., Smith, S. K. & Sharkey, A. M. 2004 Identification of genes regulated by leukemia- inhibitory factor in the mouse uterus at the time of implantation. Mol. Endocrinol. 18, 2185-2195. (doi:10.1210/me.2004-0110)
51. Niwa, H. 2007 How is pluripotency determined and maintained? Development 134, 635-646. (doi:10.1242/ dev.02787)
52. Martin, G. R. 1981 Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634-7638. (doi:10.1073/pnas.78.12.7634)
53. Evans, M. J. & Kaufman, M. H. 1981 Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156. (doi:10.1038/292154a0)
54. Thomson, J. A., Kalishman, J., Golos, T. G., Durning, M., Harris, C. P., Becker, R. A. & Hearn, J. P. 1995 Isolation of a primate embryonic stem cell line. Proc. Natl Acad. Sci. USA 92, 7844-7848. (doi:10.1073/pnas.92.17.7844)
55. Kunath, T. Primed for pluripotency. Cell Stem Cell 8, 241-242. (doi:10.1016/j.stem.2011.02.009)
56. Najm, F. J. et al. Isolation of epiblast stem cells from preimplantation mouse embryos. Cell Stem Cell 8, 318-325.
57. Ying, Q. L., Nichols, J., Chambers, I. & Smith, A. 2003 BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292. (doi:10.1016/ S0092-8674(03)00847-X)
58. Ying, Q. L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P. & Smith, A. 2008 The ground state of embryonic stem cell self-renewal. Nature 453, 519-523. (doi:10.1038/nature06968)
59. Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., Schöler, H. & Smith, A. 1998 Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391. (doi:10.1016/ S0092-8674(00)81769-9)
60. Niwa, H., Miyazaki, J. & Smith, A. G. 2000 Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376. (doi:10.1038/74199)
61. Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L., Vivian, N. & Lovell-Badge, R. 2003 Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17, 126-140. (doi:10.1101/gad.224503)
62. Chambers, I. & Tomlinson, S. R. 2009 The transcriptional foundation of pluripotency. Development 136, 2311-2322. (doi:10.1242/dev.024398)
63. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S. & Smith, A. 2003 Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655. (doi:10.1016/S0092-8674(03)00392-1)
64. Chambers, I., Silva, J., Colby, D., Nichols, J., Nijmeijer, B., Robertson, M., Vrana1, J., Jones, K., Grotewold, L. & Smith, A. 2007 Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230-1234. (doi:10.1038/nature06403)
65. Silva, J. et al. 2009 Nanog is the gateway to the pluripotent ground state. Cell 138, 722-737. (doi:10.1016/j. cell.2009.07.039)
66. Theunissen, T. W. & Silva, J. C. R. 2011 Switching on pluripotency: a perspective on the biological requirement of Nanog. Phil. Trans. R. Soc. B 366, 2222-2229. (doi:10.1098/rstb.2011.0003)
67. Hajkova, P. 2011 Epigenetic reprogramming in the germline: towards the ground state of the epigenome. Phil. Trans. R. Soc. B 366, 2266-2273. (doi:10.1098/rstb.2011.0042)
68. Chia, N. Y. et al. A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468, 316-320. (doi:10.1038/nature09531)
69. Boyer, L. A. et al. 2005 Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956. (doi:10.1016/j.cell.2005.08.020)
70. Loh, Y. H. et al. 2006 The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38, 431-440. (doi:10.1038/ng1760)
71. Kim, J., Chu, J., Shen, X.,Wang, J. & Orkin, S. H. 2008 An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132, 1049-1061. (doi:10.1016/j.cell.2008.02.039)
72. Chen, X. et al. 2008 Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106-1117. (doi:10.1016/j.cell.2008.04.043)
73. Xue, K., Ng, J.-H. & Ng, H.-H. 2011 Mapping the networks for pluripotency. Phil. Trans. R. Soc. B 366, 2238-2246. (doi:10.1098/rstb.2011.0005)
74. Wang, G., Silva, J., Krishnamurthy, K. & Bieberich, E. 2006 A novel isoform of prostate apoptosis response 4 (PAR-4) that co-distributes with Factin and prevents apoptosis in neural stem cells. Apoptosis 11, 315-325. (doi:10.1007/s10495-006-3979-8)
75. Liang, J. et al. 2008 Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 10, 731-739. (doi:10.1038/ncb1736)
76. van den Berg, D. L., Snoek, T., Mullin, N. P., Yates, A., Bezstarosti, K., Demmers, J., Chambers, I. & Poot, R. A. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell 6, 369-381. (doi:10.1016/j. stem.2010.02.014)
77. Pardo, M., Lang, B., Yu, L., Prosser, H., Bradley, A., Babu, M. M. & Choudhary, J. An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. Cell Stem Cell 6, 382-395. (doi:10.1016/j.stem.2010.03.004)
78. Osorno, R. & Chambers, I. 2011 Transcription factor heterogeneity and epiblast pluripotency. Phil. Trans. R. Soc. B 366, 2230-2237. (doi:10.1098/rstb.2011.0043)
79. Huang, S. 2011 Systems biology of stem cells: three useful perspectives to help overcome the paradigm of linear pathways. Phil. Trans. R. Soc. B 366, 2247-2259. (doi:10.1098/rstb.2011.0008)
80. Stadtfeld, M., Maherali, N., Breault, D. T. & Hochedlinger, K. 2008 Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2, 230-240. (doi:10.1016/j. stem.2008.02.001)
81. Hanna, J., Saha, K., Pando, B., van Zon, J., Lengner, C. J., Creyghton, M. P., van Oudenaarden, A. & Jaenisch, R. 2009 Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595-601. (doi:10.1038/nature08592)
82. Mikkelsen, T. S. et al. 2008 Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55. (doi:10.1038/nature07056)
83. Koche, R. P., Smith, Z. D., Adli, M., Gu, H., Ku, M., Gnirke, A., Bernstein, B. E. & Meissner, A. 2011 Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 8, 96-105. (doi:10.1016/j.stem.2010.12.001)
84. Smith, Z. D., Nachman, I., Regev, A. & Meissner, A. 2010 Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat. Biotechnol.28, 521-526. (doi:10.1038/nbt.1632)
85. Beaujean, N., Taylor, J., Gardner, J., Wilmut, I., Meehan, R. & Young, L. 2004 Effect of limited DNA methylation reprogramming in the normal sheep embryo on somatic cell nuclear transfer. Biol. Reprod. 71, 185-193. (doi:10.1095/biolreprod.103.026559)
86. Smith, S. L. et al. 2005 Global gene expression profiles reveal significant nuclear reprogramming by the blastocyst stage after cloning. Proc. Natl Acad. Sci. USA 102, 17 582-17 587. (doi:10.1073/pnas.0508952102)
87. Yang, X., Smith, S. L., Tian, X. C., Lewin, H. A., Renard, J.-P. & Wakayama, T. 2007 Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning. Nat. Genet. 39, 295-302. (doi:10.1038/ng1973)
88. Fukuda, A., Cao, F., Morita, S., Yamada, K., Jincho, Y., Tane, S., Sotomaru, Y., Kono, T. & Feil, R. 2010 Identification of inappropriately reprogrammed genes by large-scale transcriptome analysis of individual cloned mouse blastocysts. PLoS ONE 5, e11274. (doi:10.1371/journal.pone.0011274)
89. Murata, K., Kouzarides, T., Bannister, A. J. & Gurdon, J. B. 2010 Histone H3 lysine 4 methylation is associated with the transcriptional reprogramming efficiency of somatic nuclei by oocytes. Epigenet. Chromatin 3, 4. (doi:10.1186/1756-8935-3-4)
90. Jullien, J., Astrand, C., Halley-Stott, R. P., Garrett, N. & Gurdon, J. B. 2010 Characterization of somatic cell nuclear reprogramming by oocytes in which a linker histone is required for pluripotency gene reactivation. Proc. Natl Acad. Sci. USA 107, 5483-5488. (doi:10.1073/ pnas.1000599107)
91. Gurdon, J. B. et al. 1979 Reprogramming of transplanted nuclei in amphibia. Int. Rev. Cytol. Suppl., 161-178.
92. Allegrucci, C. et al. 2011 Epigenetic reprogramming of breast cancer cells with oocyte extracts. Mol. Cancer 10, 7.
93. Hajkova, P., Jeffries, S. J., Lee, C., Miller, N., Jackson, S. P. & Surani, M. A. 2010 Genome-wide reprogramming in the mouse germ line entails the base excision repair pathway. Science 329, 78-82. (doi:10.1126/ science.1187945)
94. Pereira, C. F., Terranova, R., Ryan, N. K., Santos, J., Morris, K. J., Cui, W., Merkenschlager, M., Fisher, A. G. & Roopenian, D. C. 2008 Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2. PLoS Genet. 4, e1000170. (doi:10.1371/journal.pgen.1000170)
95. Piccolo, R. M., Pereira, C. F., Cantone, I., Brown, K., Tsubouchi, T., Soza-Ried, J., Merkenschlager, M. & Fisher, A. G. 2011 Using heterokaryons to understand pluripotency and reprogramming. Phil. Trans. R. Soc. B366, 2260-2265. (doi:10.1098/rstb.2011.0004)
96. Do, J. T. & Scholer, H. R. 2004 Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 22, 941-949. (doi:10.1634/stemcells.22-6-941)
97. Pereira, C. F. & Fisher, A. G. 2009 Heterokaryon-based reprogramming for pluripotency. Curr. Protoc. Stem Cell Biol. Chapter 4: p. Unit 4B 1.
98. Pereira, C. F. et al. 2010 ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency. Cell Stem Cell 6, 547-556. (doi:10.1016/j.stem.2010.04.013)
99. Singhal, N., Graumann, J., Wu, G., Araúzo-Bravo, M. J., Han, D.W., Greber, B., Gentile, L., Mann, M. & Schöler, H. R. 2010 Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell. 141, 943-955. (doi:10.1016/j.cell.2010.04.037)
100. Ho, L., Jothi, R., Ronan, J. L., Cui, K., Zhao, K. & Crabtree, G. R. 2009 An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc. Natl Acad. Sci. USA 106, 5187-5191. (doi:10.1073/pnas.0812888106)
101. Ho, L. et al. 2009 An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc. Natl Acad. Sci. USA 106, 5181-5186. (doi:10.1073/pnas.0812889106)
102. Sullivan, G. J., Bai, Y., Fletcher, J. & Wilmut, I. 2010 Induced pluripotent stem cells: epigenetic memories and practical implications. Mol. Hum. Reprod. 16, 880-885. (doi:10.1093/molehr/gaq091)
103. Chin, M. H. et al. 2009 Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5, 111-123. (doi:10.1016/j.stem.2009.06.008)
104. Chin, M. H., Pellegrini, M., Plath, K. & Lowry, W. E. 2010 Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 7, 263-269. (doi:10.1016/j.stem.2010.06.019)
105. Newman, A. M. & Cooper, J. B. 2010 Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7, 258-262. (doi:10.1016/j.stem.2010.06.016)
106. Unternaehrer, J. J. & Daley, G. Q. 2011 Induced pluripotent stem cells for modelling human diseases. Phil. Trans. R. Soc. B 366, 2274-2285. (doi:10.1098/ rstb.2011.0017)
107. Lee, G. & Studer, L. 2011 Modelling familial dysautonomia in human induced pluripotent stem cells. Phil. Trans. R. Soc. B 366, 2286-2296. (doi:10.1098/rstb.2011.0026)
108. Lee, G. et al. 2009 Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402-406. (doi:10.1038/nature08320)
109. Sreedharan, J. et al. 2008 TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672. (doi:10.1126/science.1154584)
110. Rosen, D. R. et al. 1993 Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62. (doi:10.1038/362059a0)
111. Yang, Y. et al. 2001 The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat. Genet. 29, 160-165. (doi:10.1038/ng1001-160)
112. Hentati, A. et al. 1994 Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat. Genet. 7, 425-428. (doi:10.1038/ng0794-425)
113. Hadano, S. et al. 2001 A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 29, 166-173. (doi:10.1038/ng1001-166)
114. Ben Hamida, M., Hentati, F. & Ben Hamida, C. 1990 Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. Brain 113, 347-363. (doi:10.1093/brain/113.2.347)
115. Hand, C. K. et al. 2002 A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q. Am. J. Hum. Genet. 70, 251-256. (doi:10.1086/337945)
116. Chen, Y. Z. et al. 2004 DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 74, 1128-1135. (doi:10.1086/421054)
117. Zhao, Z. H., Chen, W.-z., Wu, Z.-y., Wang, N., Zhao, G.-x., Chen, W.-j. & Murong, S.-x. 2009 A novel mutation in the senataxin gene identified in a Chinese patient with sporadic amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 10, 118-122. (doi:10.1080/17482960802572673)
118. Hentati, A. et al. 1998 Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Neurogenetics 2, 55-60. (doi:10.1007/s100480050052)
119. Vance, C. et al. 2009 Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211. (doi:10.1126/science.1165942)
120. Ruddy, D. M. et al. 2003 Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am. J. Hum. Genet. 73, 390-396. (doi:10.1086/377157)
121. Kwiatkowski Jr, T. J. et al. 2009 Mutations in the FUS/ TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208. (doi:10.1126/science.1166066)
122. Sapp, P. C. et al. 2003 Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am. J. Hum. Genet. 73, 397-403. (doi:10.1086/377158)
123. Nishimura, A. L., Mitne-Neto, M., Silva, H. C. A., Oliveira, J. R. M., Vainzof, M. & Zatz, M. 2004 A novel locus for late onset amyotrophic lateral sclerosis/ motor neurone disease variant at 20q13. J. Med. Genet. 41, 315-320. (doi:10.1136/jmg.2003.013029)
124. Nishimura, A. L. et al. 2004 A mutation in the vesicletrafficking proteinVAPBcauses late-onset spinalmuscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75, 822-831. (doi:10.1086/425287)
125. Gellera, C., Colombrita, C., Ticozzi, N., Castellotti, B., Bragato, C., Ratti, A., Taroni, F. & Silani, V. 2008 Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis. Neurogenetics 9, 33-40. (doi:10.1007/s10048-007-0111-3)
126. Greenway, M. J. et al. 2006 ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat. Genet. 38, 411-413. (doi:10.1038/ ng1742)
127. Lambrechts, D. et al. 2003 VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet. 34, 383-394. (doi:10.1038/ng1211)
128. Crabtree, B. et al. 2007 Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochemistry 46, 11810-11818. (doi:10.1021/bi701333h)
129. Kabashi, E. et al. 2008 TARDBPmutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40, 572-574. (doi:10.1038/ng.132)
130. Gitcho, M. A. et al. 2008 TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 63, 535-538. (doi:10.1002/ana.21344)
131. Yokoseki, A. et al. 2008 TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 63, 538-542. (doi:10.1002/ana.21392)
132. Winton, M. J. et al. 2008 A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro. FEBS Lett. 582, 2252-2256. (doi:10.1016/j.febslet.2008.05.024)
133. Benajiba, L. et al. 2009 TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann. Neurol. 65, 470-473. (doi:10.1002/ana.21612)
134. Van Deerlin, V. M. et al. 2008 TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 7, 409-416. (doi:10.1016/S1474-4422 (08)70071-1)
135. Kuhnlein, P., Sperfeld, A.-D., Vanmassenhove, B., Van Deerlin, V., Lee, V. M.-Y., Trojanowski, J. Q., Kretzschmar, H. A., Ludolph, A. C. & Neumann, M.2008 Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch. Neurol. 65, 1185-1189. (doi:10.1001/archneur.65.9.1185)
136. Wilhelmsen, K. C. et al. 2004 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch. Neurol. 61, 398-406. (doi:10.1001/archneur.61.3.398)
137. Hutton, M. et al. 1998 Association of missense and 50- splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705. (doi:10.1038/31508)
138. Lynch, T. et al. 1994 Clinical characteristics of a family with chromosome 17-linked disinhibition-dementiaparkinsonism- amyotrophy complex. Neurology 44, 1878-1884.
139. Zarranz, J. J. et al. 2005 A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease. Neurology 64, 1578-1585. (doi:10.1212/01.WNL.0000160116.65034.12)
140. Parkinson, N. et al. 2006 ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67, 1074-1077. (doi:10.1212/01.wnl.0000231510.89311.8b)
141. Munch, C. et al. 2005 Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Ann. Neurol. 58, 777-780. (doi:10.1002/ ana.20631)
142. Munch, C. et al. 2004 Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63, 724-726.
143. Maruyama, H. et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465, 223-226. (doi:10.1038/nature08971)
144. Johnson, J. O. et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68, 857-864. (doi:10.1016/j.neuron.2010.11.036)
145. Boillee, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, K. & Cleveland, D. W. 2006 Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392. (doi:10.1126/ science.1123511)
146. Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T. & Eggan, K. 2007 Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 10, 608-614. (doi:10.1038/nn1885)
147. Di Giorgio, F. P., Boulting, G. L., Bobrowicz, S. & Eggan, K. C. 2008 Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 3, 637-648. (doi:10.1016/j.stem.2008.09.017)
148. Marchetto, M. C., Muotri, A. R., Mu, Y., Smith, A. M., Cezar, G. G. & Gage, F. H. 2008 Non-cellautonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 3, 649-657. (doi:10.1016/j. stem.2008.10.001)
149. Melton, D. A. 2011 Using stem cells to study and possibly treat type 1 diabetes. Phil. Trans. R. Soc. B 366, 2307-2311. (doi:10.1098/rstb.2011.0019)
150. Shadrach, J. L. & Wagers, A. J. 2011 Stem cells for skeletal muscle repair. Phil. Trans. R. Soc. B 366, 2297-2306. (doi:10.1098/rstb.2011.0027)
151. Itzhaki, I. et al. 2011 Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225-229. (doi:10.1038/nature09747)
152. ClinicalTrials.gov [Internet]. I.N., Safety Study of GRNOPC1 in Spinal Cord Injury. Bethesda, MD: National Library of Medicine (US). First received: 6 October 2010. See http://clinicaltrials.gov/ct2/show/NCT01217008?term=geron&rank=9.
153. ClinicalTrials.gov [Internet]. I.N., Pilot Investigation of Stem Cells in Stroke (PISCES). Bethesda, MD: National Library of Medicine (US). First received: 9 June 2010. See http://clinicaltrials.gov/ct2/show/NCT01151124?term=reneuron&rank=1.
154. Taylor, C. J., Bolton, E. M. & Bradley, J. A. 2011 Immunological considerations for embryonic and induced pluripotent stem cell banking. Phil. Trans. R. Soc. B 366, 2312-2322. (doi:10.1098/rstb.2011.0030)
155. Nakatsuji, N., Nakajima, F. & Tokunaga, K. 2008 HLA-haplotype banking and iPS cells. Nat. Biotechnol. 26, 739-740. (doi:10.1038/nbt0708-739)
156. Taylor, C. J., Bolton, E. M., Pocock, S., Sharples, L. D., Pedersen, R. A. & Bradley, J. A. 2005 Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366, 2019-2025. (doi:10.1016/S0140-6736 (05)67813-0)
157. Prescott, C. 2011 The business of exploiting induced pluripotent stem cells. Phil. Trans. R. Soc. B 366, 2323-2328. (doi:10.1098/rstb.2011.0047)